A controversial fertility treatment requiring three genetic parents has been approved by an FDA-appointed expert panel. This means the therapy, which eliminates rare mitochondrial diseases, could soon be legal in the US. But on the recommendation of the panel, it won’t be available to girls.
Zika is now a global emergency, and the latest in a long string of mosquito-borne viruses to afflict humanity. Mosquitoes truly suck, and the time has come to do something about them. Here’s how science will help—and why a war on mosquitoes doesn’t mean we have to wipe them off the face of the planet.
Less than a year after scientists in China became the first to genetically modify human embryos, a research team in Britain has been given the green light to perform similar work. It’s a huge moment in biotech history—one that could eventually lead to “designer babies.”
The US Centers for Medicare and Medicaid Services has delivered a strongly worded letter to blood testing startup Theranos, saying its California facility poses “immediate jeopardy to patient safety,” and that it has 10 days to comply with “acceptable evidence of correction.”
People with type 1 diabetes have to inject insulin daily, and it often results in pain, redness, swelling, and itching at the injection site. But this could soon be a thing of the past, thanks to a new breakthrough that takes us one step closer to a functional cure for type 1 diabetes.
Researchers in China have genetically engineered monkeys to exhibit autistic-like behaviors, including impaired social skills and increased anxiety. This research is poised to improve our understanding of brain disorders, but ethicists say the harm endured by these monkeys is simply not worth it.
Researchers in Germany have have grown the innermost layer of human fallopian tubes in a lab. The new technique is offering fresh insights into this essential component of the female reproductive system, while also hinting at potential new directions for the treatment of various reproductive disorders.
Another amazing year of science has come and gone, so it’s time to look ahead and see what the next year has in store. Here are Gizmodo’s most anticipated scientific and technological developments of 2016.
For the first time ever, scientists have used the CRISPR gene-editing tool to successfully treat a genetic muscle disorder in a living adult mammal. It’s a promising medical breakthrough that could soon lead to human therapies.
Researchers in France have developed a self-setting foam that can repair defects in bones and assist growth. Eventually, this advanced biomaterial could be used to quickly regenerate bone growth and treat degenerative diseases such as osteoporosis.
The blood testing start-up Theranos came under intense media scrutiny back in October. Now, the Wall Street Journal reports that U.S. health regulators are investigating complaints about the company’s lab and research practices.
It’s time to reflect on the most futuristic breakthroughs and developments of the past year. This year’s crop features a slew of remarkable scientific and technological achievements, from an actual working hoverboard to cyborgized brains. Here are 18 predictions that finally came true in 2015.
The U.S. Food and Drug Administration has given the thumbs up to a genetically modified chicken that produces a drug in its eggs. It’s the latest addition to a growing area in medicine known as “farmaceuticals.”
In vitro fertilization for humans has been around since the late 1970s, but the same can’t be said for our canine companions. But now, after decades of research, scientists have finally produced the first live, healthy puppies from frozen embryos.
Last week’s historic summit on human gene-editing has come to a close, and its organizing committee has given the go-ahead for scientists in the US to experiment on human genes — only if it doesn’t result in a pregnancy. It’s a surprisingly progressive stance. But make no mistake, human trait selection is coming.…
In a breakthrough that could lead to printable organs and an enhanced understanding of human physiology, researchers from Lawrence Livermore National Labs have 3D-printed functional blood vessels that look and function like the real thing.
A one-year-old girl diagnosed with incurable aggressive leukemia is now in remission after receiving “designer cells” from a donor. The therapy made use of a powerful new gene-editing technique that could eventually be used to treat an array of hereditary diseases.
The U.S. National Institutes of Health has stopped funding experiments in which human stem cells are transplanted into the embryo of an animal. Now, a group of researchers from Stanford University are speaking out, claiming that the restrictions are holding back important medical research—and that the NIH’s reasons…
Speaking at the Fortune Global Forum yesterday, embattled Theranos CEO Elizabeth Holmes defended her company’s blood test technology, while promising to become more transparent in the future.
Elizabeth Holmes, the beleaguered founder-and-chief of Theranos, has agreed to publish scientific data that will supposedly affirm the accuracy and reliability of its blood tests. But as a recent FDA inspection report points out, things don’t look good.